Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2021-05-24 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
公司拟进行股权收购涉及的苏州广慈肿瘤医院有限公司股东全部权益价值项目资产评估报告
Audit Report / Information Classification · 95% confidence The document is titled as an "资产评估报告" (Asset Valuation Report) and is prepared according to Chinese asset valuation standards. It is a detailed report assessing the shareholder equity value of Suzhou Guangci Tumor Hospital Co., Ltd. for a proposed equity acquisition by Yingkang Life Technology Co., Ltd. The document includes comprehensive financial data, valuation methods (asset-based and income approaches), legal and regulatory references, audit confirmations, and detailed asset and liability breakdowns. It is clearly a full asset valuation report rather than a brief announcement or a certification. The document length is substantial (15,000 characters), and it contains substantive financial and valuation analysis. This type of document fits best under the category of an Audit Report / Information (AR), as it is a standalone asset valuation report prepared by an asset appraisal firm, including audit references but not a full annual report or earnings release. It is not an Annual Report (10-K), nor a Management Report (MDA), nor a Regulatory Filing (RNS). Therefore, the appropriate classification is AR with high confidence. FY 2020
2021-05-24 Chinese
董事会关于本次交易履行法定程序完备性、合规性及提交法律文件的有效性的说明
Regulatory Filings Classification · 95% confidence The document is a detailed explanation from the board of directors of 盈康生命科技股份有限公司 regarding the completeness, compliance, and validity of legal documents submitted for a major asset restructuring transaction. It references relevant laws and regulations, describes the procedural steps taken including board and supervisory meetings, approvals, and legal compliance. The content focuses on the procedural and legal compliance aspects of a major asset acquisition transaction, not on financial results or earnings. It is not a full financial report, earnings release, or investor presentation. It is also not a simple announcement or certification but a substantive explanation related to a major asset restructuring transaction. This fits the category of a Regulatory Filing (RNS) as it is a regulatory disclosure about a corporate transaction and compliance, without being a full report or financial statement.
2021-05-24 Chinese
关于暂不召开股东大会审议本次重组相关事项的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding the decision to temporarily not hold a shareholders' meeting to review matters related to a major asset restructuring. It references regulatory requirements and previous disclosures but does not contain financial statements or detailed financial data. The document is short (689 characters) and serves as a formal notification about corporate governance actions related to a restructuring process, specifically the postponement of a shareholders' meeting. This fits best under Regulatory Filings (RNS) as it is a general regulatory announcement and does not qualify as a full report, meeting materials, or voting results.
2021-05-24 Chinese
2020年年度报告（更新后）
Annual Report Classification · 100% confidence The document is titled "盈康生命科技股份有限公司 2020 年年度报告全文" which translates to "INKON Life Technology Co., Ltd. 2020 Annual Report Full Text." It contains detailed sections including company overview, financial data for the year 2020, business overview, management statements, and audited financial figures. The document references the full fiscal year 2020 (January 1 to December 31, 2020) and includes comprehensive financial and operational information. It is clearly the full annual report of the company for the year 2020, not just an announcement or summary. The length of the document (15,000 characters) and the detailed content confirm it is the full Annual Report (10-K equivalent). FY 2020
2021-05-24 Chinese
2020年年度审计报告（更新后）
Audit Report / Information Classification · 100% confidence The document is titled as an "审计报告" which translates to "Audit Report" for the fiscal year 2020. It contains detailed audit opinions, basis for audit opinions, key audit matters, responsibilities of management and auditors, and extensive financial statements including consolidated and parent company balance sheets, income statements, cash flow statements, and notes. The presence of an auditor's opinion from a registered accounting firm and detailed financial data confirms this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters) and contains actual financial data and audit details, so it is not merely an announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2020
2021-05-24 Chinese
更正公告
Regulatory Filings Classification · 95% confidence The document is a correction announcement related to the company's previously disclosed 2020 Annual Report and 2020 Annual Audit Report. It specifies corrections to financial data in the annual report and audit report sections, but it is not the full annual report or audit report itself. The document length is short (2241 characters) and it states that the corrected reports will be disclosed on the website. This fits the pattern of a report correction or announcement rather than the full report. Given the nature of the content and the short length, it is best classified as a Regulatory Filing (RNS) because it is a correction announcement and does not contain the full annual report or audit report data itself.
2021-05-24 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.